Lymphotoxin
(Redirected from Tumor necrosis factor-beta)
lymphotoxin alpha (TNF superfamily, member 1) | |
---|---|
Identifiers | |
Symbol | LTA |
Alt. symbols | TNFB |
Entrez | 4049 |
HUGO | 6709 |
OMIM | 153440 |
RefSeq | NM_000595 |
UniProt | P01374 |
Other data | |
Locus | Chr. 6 p21.3 |
lymphotoxin beta (TNF superfamily, member 3) | |
---|---|
Identifiers | |
Symbol | LTB |
Alt. symbols | TNFC |
Entrez | 4050 |
HUGO | 6711 |
OMIM | 600978 |
RefSeq | NM_002341 |
UniProt | Q06643 |
Other data | |
Locus | Chr. 6 p21.3 |
Lymphotoxin (previously known as tumor necrosis factor-beta) is a lymphokine cytokine.
It is a protein that is produced by Th1 type T-cells and induces vascular endothelial cells to change their surface adhesion molecules to allow phagocytic cells to bind to them.[1] It is also known to be required for normal development of Peyer's patches.[2]
Lymphotoxin is homologous to Tumor Necrosis Factor beta, but secreted by T-cells. It is paracrine due to the small amounts produced. The effects are similar to TNF-alpha, but TNF-beta is also important for the development of lymphoid organs.
See also
References
- ↑ Parham, Peter (2005). "Chapter 6: T-cell mediated immunity". The immune system (2nd ed.). New York: Garland Science. p. 172. ISBN 0-8153-4093-1.
- ↑ Kumar. "Chapter 13 – Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus". In Kumar. Robbins and Cotran Pathologic Basis of Disease, Professional Edition (8th ed.).
External links
- Lymphotoxin at the US National Library of Medicine Medical Subject Headings (MeSH)
This immunology article is a stub. You can help Wikipedia by expanding it. |